Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SPIMACO
Riyadh, Riyadh, Saudi Arabiaspimaco.com.sa ↗
- Ownership
- Private
- Employees
- ~1182
- Development stage
- Other
01
Overview
SPIMACO is one of the largest pharmaceutical companies in the Middle East and North Africa, producing over 2 billion units yearly across 16 countries. It has leading sales in Saudi Arabia's private sector, active research collaborations (including with WHO), major manufacturing agreements, and ongoing expansion into cancer drugs and biopharmaceuticals. Clinical result summaries for pipeline programs are not publicly available.
- Therapeutic areas
- OncologyInfectious DiseasesOther
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
AstraZeneca (manufacturing agreement)World Health Organisation (research collaboration)Leading drug manufacturers (undisclosed details)
Beyond the preview
Go deeper on SPIMACO.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SPIMACO.